Literature DB >> 24500787

The OPTI-MIND study: a prospective, observational study of pacemaker patients according to pacing modality and primary indications.

Mauro Biffi1, Donato Melissano, Paolo Rossi, Gabriela Kaliska, Aleš Havliĉek, Gemma Pelargonio, Rafael Romero, Ciro Guastaferro, Maurizio Menichelli, Elisa Vireca, Jessica Frisoni, Giuseppe Boriani, Tibor Malacky.   

Abstract

AIMS: The OPTI-MIND study aims to collect 2-year clinical outcomes of pacemaker patients in real-world clinical practice, overall and according to patient characteristics and pacemaker settings. METHODS AND
RESULTS: The present analysis of the OPTI-MIND study describes the programmed device settings after discharge from the pacemaker implant. The objective was to determine whether these settings fit recent guidelines for device-programmed physiological pacing based on the preservation of atrioventricular synchrony, avoiding unnecessary pacing, ensuring rate increase during exercise or preventing neurally mediated symptoms. A total of 1740 patients were enroled at 68 centres worldwide. Baseline patient characteristics and device programming settings are available in 1674 of 1740 patients (96%). Guidelines to ensure physiological pacing were followed in 41% of patients: in patients with sinus node disease (SND), and without atrioventricular block (AVB), device programming could have led to unnecessary right ventricular pacing in 38% of patients. In SND patients with chronotropic incompetence, assisted rate increase during exercise was not programmed in 42% of patients. In 11% of patients with AVB, atrioventricular (AV) synchrony was not pursued; the main drivers being advanced age and history of atrial fibrillation. Patients with both SND and AVB were generally programmed physiologically (87%).
CONCLUSION: The present analysis showed that frequent deviations occurred when comparing the device settings at discharge from the pacemaker implant in clinical practice to the available guidelines on pacing mode selection. Analysis of 2-year outcomes in the OPTI-MIND study will provide an insight into whether specific physiological settings could improve the quality of pacing with a positive effect on patient outcome.

Entities:  

Keywords:  Bradyarrhythmia; Cardiac pacing; Pacemaker; Reprogramming

Mesh:

Year:  2014        PMID: 24500787     DOI: 10.1093/europace/eut387

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  An approach towards individualized lower rate settings for pacemakers.

Authors:  Margaret Infeld; Robert Avram; Kramer Wahlberg; Daniel N Silverman; Nicole Habel; Daniel L Lustgarten; Mark J Pletcher; Jeffrey E Olgin; Gregory M Marcus; Markus Meyer
Journal:  Heart Rhythm O2       Date:  2020-10-06

2.  Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: Design and rationale for the myPACE randomized controlled trial.

Authors:  Margaret Infeld; Kramer Wahlberg; Jillian Cicero; Sean Meagher; Nicole Habel; Anand Muthu Krishnan; Daniel N Silverman; Daniel L Lustgarten; Markus Meyer
Journal:  Heart Rhythm O2       Date:  2021-12-07

3.  Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial.

Authors:  Martin Stockburger; Pascal Defaye; Serge Boveda; Branislav Stancak; Arnaud Lazarus; Johann Sipötz; Stefano Nardi; Mara Rolando; Javier Moreno
Journal:  Europace       Date:  2015-11-26       Impact factor: 5.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.